saphnelohcp.com - SAPHNELO – A Treatment Option for Lupus | For HCPs

home > domains > saphnelohcp.com

Description: SAPHNELO® (anifrolumab-fnia) Injection, For Intravenous Use is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy.

Example domain paragraphs

For US Healthcare Professionals

Reduced disease activity

Established safety profile from clinical trials

Links to saphnelohcp.com (3)

• saphnelo.com SAPHNELO for Lupus | Systemic Lupus Erythematosus Treatment
• saphnelosafety.com Safety | SAPHNELO® (anifrolumab-fnia) Injection for Intravenous Use 300 mg/vial
• lupus-treatment.com SAPHNELO for Lupus | Systemic Lupus Erythematosus Treatment